Paris, France

Jacques Leibowitch

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jacques Leibowitch

Introduction

Jacques Leibowitch, an accomplished inventor based in Paris, France, has made significant strides in the field of pharmaceuticals, particularly focusing on the treatment of the human immunodeficiency virus (HIV). With a total of three patents to his name, Leibowitch stands out as a pivotal figure in the innovation landscape of HIV treatment methodologies.

Latest Patents

Leibowitch's recent patents focus on advanced schedules for administering combination therapies aimed at treating individuals afflicted with HIV. His patents involve innovative pharmaceutical compositions that utilize combinations of active principles. These include nucleoside reverse transcriptase inhibitors (NRTIs), such as lamivudine and emtricitabine, along with nucleoside or nucleotide reverse transcriptase inhibitors selected from didanosine, abacavir, and tenofovir, in addition to various protease inhibitors and non-nucleoside reverse transcriptase inhibitors. These inventive strategies facilitate effective daily administration routines, optimizing treatment efficacy by allowing for administration one to four days per week.

Career Highlights

Leibowitch's career is marked by his contributions to the scientific community, particularly during his tenure at the University of Versailles Saint-Quentin-en-Yvelines. His academic and professional journey has been instrumental in guiding his innovative approaches to HIV treatment, combining rigorous research with practical applications.

Collaborations

Throughout his career, Jacques Leibowitch has worked with esteemed institutions such as the University of Versailles Saint-Quentin-en-Yvelines. His collaborations have enriched his research endeavors, enabling the development of robust solutions to complex medical challenges.

Conclusion

In summary, Jacques Leibowitch is a notable inventor whose work in the field of HIV treatment exemplifies the essence of innovation and dedication. His patents not only showcase his ingenuity but also reflect his commitment to improving the lives of those affected by HIV. As the landscape of pharmaceutical innovations continues to evolve, Leibowitch's contributions will undoubtedly leave a lasting impact.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…